4//SEC Filing
Jorgensen Nathan D. 4
Accession 0001209191-23-054696
CIK 0001817229other
Filed
Nov 7, 7:00 PM ET
Accepted
Nov 8, 4:12 PM ET
Size
4.8 KB
Accession
0001209191-23-054696
Insider Transaction Report
Form 4
Jorgensen Nathan D.
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2023-11-06$1.82/sh−834$1,518→ 145,647 total
Footnotes (1)
- [F1]Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units.
Documents
Issuer
Vor Biopharma Inc.
CIK 0001817229
Entity typeother
Related Parties
1- filerCIK 0001842523
Filing Metadata
- Form type
- 4
- Filed
- Nov 7, 7:00 PM ET
- Accepted
- Nov 8, 4:12 PM ET
- Size
- 4.8 KB